Impiricus Rises to Prominence as North America's Fastest-Growing Tech Company by Deloitte

Impiricus Named the Fastest-Growing Company in North America by Deloitte

In an impressive achievement, Impiricus has been named the fastest-growing company on Deloitte's prestigious 2025 Technology Fast 500™ list. This annual ranking, now celebrating its milestone 31st year, highlights the top 500 fastest-growing firms across various sectors including technology, media, life sciences, and fintech in North America. With an astounding growth rate of 29,738%, Impiricus outperformed hundreds of other dynamic companies spanning 36 states in the U.S. and nine Canadian provinces.

Leading in AI

Alongside its overall ranking, Impiricus also secured the top spot in the Artificial Intelligence category. This recognition not only affirms the remarkable growth of the company but also emphasizes its pivotal role in developing AI platforms that focus on ethical physician engagement. The average growth rate for companies featured in the 2025 Technology Fast 500 ranged from 122% to the extraordinary rate exhibited by Impiricus, which reflects a profound shift in the industry.

Founded by a practicing physician and a former pharmaceutical executive, Impiricus has revolutionized the way healthcare professionals connect with essential pharmaceutical resources. Its innovative AI-powered Healthcare Provider (HCP) Engagement Engine gives doctors unprecedented control over how, when, and what information they receive, allowing for a personalized experience that prioritizes patient needs. This methodology not only enhances clinical support but also reduces market entry costs while expediting the delivery of vital treatments to patients.

Statement from Leadership

According to Dr. Osama Hashmi, Co-founder and CEO of Impiricus, the acknowledgment as the top-ranked company signals the trust that both physicians and pharmaceutical partners have in their solutions. He stated, "This recognition reflects the trust physicians and pharmaceutical companies have placed in our solutions and underscores the urgency of modernizing how resources reach the front lines of care. Leading the Fast 500 is a milestone for Impiricus and marks a shift toward AI-driven tools that expand access to treatments and support historically underserved healthcare providers."

Sandy Donaldson, Co-founder and President of Impiricus, echoed this sentiment, noting, "Ranking #1 reinforces the impact our technology is having across the healthcare ecosystem. As we continue to innovate quickly, we remain committed to building ethical, transparent AI solutions that support underserved physicians and ultimately improve patient outcomes."

The 2025 ranking emphasizes the rapid advancement of AI companies and the growing importance of agility, data sophistication, and platform-driven growth in the current market. Impiricus' impressive ascent underscores how swiftly AI is transforming traditional models of physician engagement, clinical communication, and workflow optimization.

Conclusion

Impiricus is not just a burgeoning company; it represents a beacon of growth and innovation in the healthcare technology sector. As the first and only AI-powered HCP Engagement Engine, its mission is clear: to ethically bridge the gap between healthcare providers and pharmaceutical resources, ensuring that life-changing treatments reach those in need without compromising the integrity of the physician-patient relationship. The future looks promising for Impiricus as it paves the way for a new era in healthcare driven by technology and innovation.

For further insights about the companies in Deloitte’s 2025 Technology Fast 500™, you can visit Deloitte's official rankings page.